HC Wainwright & Co. analyst Robert Burns downgrades TCR2 Therapeutics (NASDAQ:TCRR) from Buy to Neutral.
Bitcoin, Ethereum, Dogecoin Mixed Amid Profit-Taking Frenzy: Analyst Says King Crypto Prime For Parabolic Surge, Mirroring Amazon’s 2010 Recovery
The major cryptocurrencies displayed a mixed performance on Sunday evening as Bitcoin, the world’s largest cryptocurrency, seemed to be undergoing a correction, while some altcoins were experiencing significant gains.
